Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alnylam Pharmaceuticals, Inc.
Therapeutic RNA interference company says senior management team expanded
May 14th, 2003
Alnylam Pharmaceuticals, Inc., announced the appointment of two senior executives to the company's management team. Victor E. Kotelianski, MD, PhD, has been appointed to the position of vice president of research and operations and David M. Konys has been appointed to the position of vice president of corporate development. "Alnylam is very pleased to welcome Kotelianski and Konys, both of whom are highly respected in their fields," said John Maraganore, president and CEO of Alnylam. "With their broad biotech expertise, Kotelianski and Konys will significantly strengthen Alnylam's capabilities as we continue to build our team." ...
Source: Biotech Week (2003-05-14)
|
